The former board did a great disservice to shareholders in gifting this company to Couchman. We are completely in the dark as to where this investment is headed. I believe Orwin & company handed control over as soon as they thought the had secured all the waivers through the lawsuits. I would love to hear from an attorney about suing the counsels for the shareholders for their failure to represent shareholders as they claimed. They were well compensated for delivering waivers forced upon unknowing victims. It is outrageous that shareholders must opt out of settlements they haven't participated in. At least opt in would require they were aware and would avoid these unjust rulings.
Nice find and thanks for sharing. Interesting in the difference with SUV compared to MUV. There has to be more to this as you would think this could be reformulated or given to patients for those needing less than 10MG.'s. Other failed drugs are re launched with niche populations. I would think this could be too.,
Excellent find...great news but who control's the patent's now? Management should have had the guts to stay with company..
lawsuits will be coming out of the wood work
other then that its great news
i dont understand this.. can you please explain to me?
google this: Subvisible Particle Content, Formulation, and Dose of an
Erythropoietin Peptide Mimetic Product Are Associated With Severe
Adverse Postmarketing Events
Not a buyout but a buy in. In order to keep the NOL tax loss carryforward, there can't be a change in control. So AFFY will need to acquire another profitable company, possibly in the vitamin industry, which is somewhat similar to the drug industry, but doesn't require FDA approval.
Another 300K+ day. Wonder if these buyers know Couchman or if its not Couchman himself through other accounts.
Let's hope its not Couchman getting ready to screw small shareholders with his reverse split - split special.
I can't believe they allow him to do that. And I can't believe the BOD was allowed to hand the company over to him. Did anyone vote for him. They are crooks and I've try to expose them to the authorities without success.
It didn't surprise me to find no actions taken for the manipulations that occurred with this stock.
With the DOW down nearly 500 pts affy has buying interest over 260k shares.
I hope to visit the IRS soon and ask if this is a tax fraud scheme.
this stock shouldnt even be trading but yet it continues to trade...I believe the shareholders have been shammed...This is one for the history books.. There should be a investigation into the people behind robbing this company.I wont be surprised to see this back into play very sooooooooooooooooooon$$$ in a theater near us all.
Thank you. I am not very familiar with NOLs so how can it translate into a higher pps? Does a private group come and buy the company with all its NOLs for $100 mill and that is like $2.75 per share? Just am example.....
I assume sometime this spring the window for filing lawsuits will be closed. Someone else may have more info on the lawsuit filing statutes but I believe its around two years. Any private company wanting to go public would not touch this shell until that issue is resolved. As far as the NOLs, they could possibly a great benefit to a company that has profits they want to shelter. What I have never been able to find out is what is actually on the books now for NOLs. So there may be a great value locked up in NOLs or not so much.
When does that limitation run out? I am most interested in how NOLs cam help shareholders. I do not care about past problems of the past. How is this stock going to go up is all I care about. Why will the stock price run after the limitations run out? A reverse merger. How will that help the pps? We have had no word of any kind from AFFY since Nov. 26, 2014. What could happen to help the pps rise? Maybe they have patents that have some value. Answers appreciated.
For services rendered in withholding crucial information concerning Omontys' major customer namely Fresenius on its decision to stop using Omontys on Feb.22,2013. Note lawyers in both suits against Orwin refused to include this event in the complaints and delivered waivers to the former insiders and BOD.
One might even ask if Orbimed uses it seats on the boards to trade on non public information.
Take a look at John's good fortune at Relypsa where Orbimed hired him early in the Affymax debacle.
Must be nice 40,000 at $25. Is that a show of confidence or is the man smart enough to take a quick $700K profit just in case something goes wrong? Is he leaving $2 million on the table if this is going to $75.
But don't cry for him he still has options on 800,000 shares and maybe a bonus in January.
I not saying Rlyp is a bad investment and won't be bought out and I congratulate you all, just wondering why Orbimed granted him nearly a million shares.
What a shock, Relypsa has a deal with Fresenius. I don't think the Amgen connection here is worth mentioning.
Thank you. A substantial part which is limited is the number I was looking to get. Must be top secret in affy HQ. I may add a position soon. After the statute of limitations has run out on filing lawsuits this may run.